Azathioprine versus Mycophenolate Mofetil, Comparing Effectiveness for Treatment of Generalized Myasthenia Gravis

Curious about which immunosuppressant is most efficacious for treatment of Myasthenia Gravis? In this episode, Vonda Elmer, R. EEG/EP. T, R. NCS. T, CNCT will talk with Donald Sanders, MD, professor emeritus of neurology at Duke University School of Medicine and lead author of the recently published data from The Duke MG Patient Registry comparing the effectiveness of Azathioprine and Mycophenolate Mofetil in generalized Myasthenia Gravis. Dr. Sanders will share the details and findings of this interesting retrospective single-center review.